Amundi Asset Management US’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,600	Closed	-$74K	–	1589
2018 Q3	$74K	Hold	8,600	–	–	﹤0.01%	1501
2018 Q2	$94K	Buy	+8,600	New	+$94K	﹤0.01%	1469